SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000905148-24-001625
Filing Date
2024-05-24
Accepted
2024-05-24 16:07:59
Documents
1
Period of Report
2024-05-22

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 2831
  Complete submission text file 0000905148-24-001625.txt   4497
Mailing Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335
Business Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335 248-681-9815
Ocuphire Pharma, Inc. (Issuer) CIK: 0001228627 (see all company filings)

IRS No.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 37000 GRAND RIVER AVE SUITE 120 FARMINGTON HILLS MI 48335
Business Address
Jayagopal Ashwath (Reporting) CIK: 0002008983 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34079 | Film No.: 24984328